Medico Remedies

{
  "main_header": {
    "sid": 1002925,
    "name": "Medico Remedies",
    "stock_name": "Medico Remedies",
    "full_name": "Medico Remedies Ltd",
    "name_url": "stocks-analysis/medico-remedies",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "49.12",
    "chg": -0.47,
    "chgp": "-0.95%",
    "dir": -1,
    "prev_price": "49.59",
    "mcapval": "411.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540937,
    "symbol": "MEDICO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE630Y01024",
    "curr_date": "Feb 11",
    "curr_time": "",
    "bse_nse_vol": "8.62 k",
    "exc_status": "Active",
    "traded_date": "Feb 11, 2026",
    "traded_date_str": "2026 02 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medico-remedies-1002925-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Medico Remedies Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-medico-remedies-ltd-3831889",
        "imagepath": "",
        "date": "2026-02-10 23:18:14",
        "description": "The next results date for Medico Remedies Ltd is scheduled for 12 February 2026...."
      },
      {
        "title": "Medico Remedies Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-hold-3818027",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MedicoRemediesL_mojoScore_3818027.png",
        "date": "2026-02-03 10:10:04",
        "description": "Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Medico Remedies Ltd Surges to Upper Circuit on Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-surges-to-upper-circuit-on-robust-buying-pressure-3801816",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MedicoRemediesL_stocks_hitting_upper_circuit_3801816.png",
        "date": "2026-01-23 13:00:13",
        "description": "Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit limit on 23 Jan 2026, registering a maximum daily gain of 10.0%. This sharp rally was driven by strong buying interest, significant volume expansion, and a notable increase in delivery volumes, signalling heightened investor confidence despite a recent downgrade in its mojo grade."
      },
      {
        "title": "Medico Remedies Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-hold-3801534",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MedicoRemediesL_mojoScore_3801534.png",
        "date": "2026-01-23 10:10:03",
        "description": "Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Medico Remedies Ltd Surges to Upper Circuit on Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-surges-to-upper-circuit-on-robust-buying-pressure-3800485",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MedicoRemediesL_stocks_hitting_upper_circuit_3800485.png",
        "date": "2026-01-22 15:00:10",
        "description": "Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit limit on 22 Jan 2026, propelled by strong buying momentum and heightened investor participation. The stock closed at ₹49.31, marking a near 10% gain on the day, significantly outperforming its sector and benchmark indices amid a volatile trading session."
      },
      {
        "title": "Medico Remedies Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-hold-3789661",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MedicoRemediesL_mojoScore_3789661.png",
        "date": "2026-01-12 10:10:52",
        "description": "Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Why is Medico Remedies Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-medico-remedies-ltd-fallingrising-3787759",
        "imagepath": "",
        "date": "2026-01-10 01:36:27",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Medico Remedies Ltd closed at ₹48.00 on 09 January, down by ₹0.46 or 0.95% from the previous session. This decline continues a five-day losing streak, during which the stock has fallen by 5.25%. This underperformance is more pronounced than the broader Sensex index, which declined by 2.55% over the same one-week period. The stock’s year-to-date return also trails the benchmark, with a 5.06% drop compared to Sensex’s 1.93% fall.</p>\n<p>Over the longer term, the stock has struggled relative to the market. While the Sensex has delivered a 7.67% gain over the past year, Medico Remedies has declined by 21.18%. Even over three years, the stock is down 28.20%, contrasting sharply with the Sensex’s 37.58% rise. However, the five-year return re..."
      },
      {
        "title": "Medico Remedies Downgraded to Hold Amid Mixed Technicals and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-downgraded-to-hold-amid-mixed-technicals-and-valuation-concerns-3775834",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MedicoRemediesL_mojoScore_3775834.png",
        "date": "2025-12-31 08:19:55",
        "description": "Medico Remedies Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 30 December 2025. This adjustment reflects a nuanced reassessment across quality, valuation, financial trends, and technical indicators, signalling a more cautious stance despite the company’s solid financial performance and operational strengths."
      },
      {
        "title": "Medico Remedies Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-buy-3769183",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MedicoRemediesL_mojoScore_3769183.png",
        "date": "2025-12-25 12:58:03",
        "description": "Medico Remedies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook."
      }
    ],
    "total": 160,
    "sid": "1002925",
    "stock_news_url": "https://www.marketsmojo.com/news/medico-remedies-1002925"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company",
      "datetime": "07-Feb-2026",
      "details": "Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve 1. Unaudited Financial Results for the quarter ended 31st December 2025 along with the Limited Review Report thereon; 2. Any other business with the permission of the Chair",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "27-Jan-2026",
      "details": "Please find attached requisite disclosure",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "20-Jan-2026",
      "details": "Please find attached Intimation under Regulation 30 of SEBI LODR Regulations 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Medico Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 16 Mar 23",
          "dt": "2023-03-16",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Medico Remedies Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 16 Nov 21",
          "dt": "2021-11-16",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

When is the next results date for Medico Remedies Ltd?

2026-02-10 23:18:14

The next results date for Medico Remedies Ltd is scheduled for 12 February 2026....

Read full news article

Medico Remedies Ltd is Rated Hold

2026-02-03 10:10:04

Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Medico Remedies Ltd Surges to Upper Circuit on Robust Buying Pressure

2026-01-23 13:00:13

Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit limit on 23 Jan 2026, registering a maximum daily gain of 10.0%. This sharp rally was driven by strong buying interest, significant volume expansion, and a notable increase in delivery volumes, signalling heightened investor confidence despite a recent downgrade in its mojo grade.

Read full news article

Medico Remedies Ltd is Rated Hold

2026-01-23 10:10:03

Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Medico Remedies Ltd Surges to Upper Circuit on Robust Buying Pressure

2026-01-22 15:00:10

Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit limit on 22 Jan 2026, propelled by strong buying momentum and heightened investor participation. The stock closed at ₹49.31, marking a near 10% gain on the day, significantly outperforming its sector and benchmark indices amid a volatile trading session.

Read full news article

Medico Remedies Ltd is Rated Hold

2026-01-12 10:10:52

Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Why is Medico Remedies Ltd falling/rising?

2026-01-10 01:36:27

Recent Price Movement and Market Context

Medico Remedies Ltd closed at ₹48.00 on 09 January, down by ₹0.46 or 0.95% from the previous session. This decline continues a five-day losing streak, during which the stock has fallen by 5.25%. This underperformance is more pronounced than the broader Sensex index, which declined by 2.55% over the same one-week period. The stock’s year-to-date return also trails the benchmark, with a 5.06% drop compared to Sensex’s 1.93% fall.

Over the longer term, the stock has struggled relative to the market. While the Sensex has delivered a 7.67% gain over the past year, Medico Remedies has declined by 21.18%. Even over three years, the stock is down 28.20%, contrasting sharply with the Sensex’s 37.58% rise. However, the five-year return re...

Read full news article

Medico Remedies Downgraded to Hold Amid Mixed Technicals and Valuation Concerns

2025-12-31 08:19:55

Medico Remedies Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 30 December 2025. This adjustment reflects a nuanced reassessment across quality, valuation, financial trends, and technical indicators, signalling a more cautious stance despite the company’s solid financial performance and operational strengths.

Read full news article

Medico Remedies Ltd is Rated Buy

2025-12-25 12:58:03

Medico Remedies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook.

Read full news article

View All News